Inflammatory, Hematological, and Biochemical Biomarkers in COVID‐19 Patients

Rebeccah M Ayako, Kirtika Patel, Isaac Ndede, Johan Nordgren, Marie Larrson, Simeon K Mining · 2024

Read Inflammatory, Hematological, and Biochemical Biomarkers in COVID‐19 Patients by Rebeccah M Ayako, Kirtika Patel, Isaac Ndede, Johan Nordgren, Marie Larrson, Simeon K Mining (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621974.txt.

Description

Rebeccah Ayako and five colleagues published a 2024 study on blood markers in COVID-19 patients. The illness can jump from mild to life-threatening with little warning. Few lab signs reliably tell at admission who will worsen.

The team tested three families of blood markers: inflammation, blood counts, and body chemistry. They checked how well each tracks the course and severity of disease. A good marker set could sort patients early and aim care where it is needed most. The study weighs which markers earn a place in that early sort. Such sorting matters most where hospital beds and staff are scarce.

Catalog record

CREATORRebeccah M Ayako, Kirtika Patel, Isaac Ndede, Johan Nordgren, Marie Larrson, Simeon K Mining
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11621974

Browse the full library · About the Tower of Babel